IPO Boutique

Solid Biosciences Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Solid Biosciences Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Solid Biosciences Inc.SLDB -
NASDAQ
$18.00-$19.00 $16.00 $25.507.5 million1/25/2018
J.P. Morgan, Goldman Sachs & Co., Leerink Partners
Co-Manager(s):
Nomura, Chardan
Health Care
Filing(s):

Filed 2017-12-29
Terms Added 2018-01-16
Updated Terms 2018-01-24
Revised Prospectus 2018-01-25
Final Prospectus 2018-01-01
Final Prospectus 2018-01-29



Solid Biosciences Inc. Quote & Chart - Click for current quote - SLDB

About Solid Biosciences Inc. (adapted from Solid Biosciences Inc. prospectus):
Their mission is to cure Duchenne muscular dystrophy, or DMD, a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "SLDB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved